BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 336245)

  • 1. Bromocriptine suppression of plasma growth hormone in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1977 Oct; 7(4):273-81. PubMed ID: 336245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine therapy in acromegaly.
    Sachdev Y; Gomez-Pan A; Tunbridge WM; Duns A; Weightman DR; Hall R; Goolamali SK
    Lancet; 1975 Dec; 2(7946):1164-8. PubMed ID: 53655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine therapy in eleven patients with acromegaly.
    Lundin L; Ljunghall S; Wide L; Boström H
    Acta Endocrinol Suppl (Copenh); 1978; 216():207-16. PubMed ID: 347863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gel filtration studies of serum growth hormone in acromegaly following bromocriptine administration.
    Benker G; Sandmann K; Tharandt L; Hackenberg K; Reinwein D
    Horm Res; 1979; 11(3):151-60. PubMed ID: 488905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acromegaly with bromocryptine.
    Steinbeck K; Turtle JR
    Aust N Z J Med; 1979 Jun; 9(3):217-24. PubMed ID: 288386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine treatment in acromegaly: clinical and biochemical effects.
    Halse J; Haugen HN; Bohmer T
    Acta Endocrinol (Copenh); 1977 Nov; 86(3):464-72. PubMed ID: 335755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutical effects of bromocriptine (CB 154) in 10 acromegalic subjects. Study of somatotrophic function and clinical survey (author's transl)].
    Fossati P; Asfour M; Brion-Brevan B; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Blacker C
    Ann Endocrinol (Paris); 1977; 38(4):291-301. PubMed ID: 332054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term bromocriptine treatment and somatostatin in acromegaly.
    Gáspár L; László FA
    Endokrinologie; 1980 Oct; 76(2):152-62. PubMed ID: 6108852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of acromegaly to long term bromocriptine therapy: a biochemical and clinical assessment.
    Clayton RN; Vrionides Y; Lynch SS; Butt WR; London DR
    Acta Endocrinol (Copenh); 1978 Nov; 89(3):469-82. PubMed ID: 360752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of treatment with sodium valproate on plasma growth hormone in bromocriptine unresponsive acromegaly.
    Nortier JW; Croughs RJ; Schwarz F; Thijssen JH
    Acta Endocrinol (Copenh); 1986 Feb; 111(2):162-4. PubMed ID: 3082095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of acromegaly using bromocriptine].
    Köbberling J; Schwinn G; Dirks H
    Dtsch Med Wochenschr; 1975 Jul; 100(29):1540-2. PubMed ID: 1149634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bomocriptine treatment of patients with acromegaly resistant to conventional therapy.
    Pelkonen R; Ylikahri R; Karonen SL
    Clin Endocrinol (Oxf); 1980 Mar; 12(3):219-24. PubMed ID: 6993053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of bromocriptine to alter the qualitative characteristics of human growth hormone in acromegaly.
    Hizuka N; Hendricks CM; Roth J; Gorden P
    Metabolism; 1984 Jun; 33(6):582-4. PubMed ID: 6727657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine treatment of acromegaly: possible dose dependency of the tumor size-reducing effect.
    Gross DJ; Halperin Y; Gomori JM; Glaser B
    Isr J Med Sci; 1989 May; 25(5):256-60. PubMed ID: 2498229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs.
    Lamberts SW; Zweens M; Verschoor L; del Pozo E
    J Clin Endocrinol Metab; 1986 Jul; 63(1):16-9. PubMed ID: 2872225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests.
    Nortier JW; Croughs RJ; Thijssen JH; Schwarz F
    Clin Endocrinol (Oxf); 1984 May; 20(5):565-71. PubMed ID: 6744634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences with bromocriptine treatment in acromegaly--a preliminary report.
    Nilsson A
    Acta Endocrinol Suppl (Copenh); 1978; 216():217-24. PubMed ID: 274038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acromegaly with bromocriptine.
    Steinbeck K; Turtle JR
    Med J Aust; 1978 Nov; 2(3 Suppl):35-6. PubMed ID: 745581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine treatment of acromegaly.
    Cassar J; Mashiter K; Joplin GF
    Metabolism; 1977 May; 26(5):539-46. PubMed ID: 576725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with 2-Br-alpha-ergocryptine in acromegaly.
    Belforte L; Camanni F; Chiodini PG; Liuzzi A; Massara F; Molinatti GM; Müller EE; Silvestrini F
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):235-48. PubMed ID: 405832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.